Regulation of the interaction between the neuronal BIN1 isoform 1 and Tau proteins – role of the SH3 domain
暂无分享,去创建一个
[1] P. Verstreken,et al. Loss of Bin1 Promotes the Propagation of Tau Pathology. , 2016, Cell reports.
[2] A. Rodal,et al. Coordinated autoinhibition of F-BAR domain membrane binding and WASp activation by Nervous Wreck , 2016, Proceedings of the National Academy of Sciences.
[3] Richard C. Rice,et al. Predominant expression of Alzheimer’s disease-associated BIN1 in mature oligodendrocytes and localization to white matter tracts , 2016, Molecular Neurodegeneration.
[4] S. Seshadri,et al. Subcellular Changes in Bridging Integrator 1 Protein Expression in the Cerebral Cortex During the Progression of Alzheimer Disease Pathology , 2016, Journal of neuropathology and experimental neurology.
[5] S. Tsuji,et al. BIN1 regulates BACE1 intracellular trafficking and amyloid-β production. , 2016, Human molecular genetics.
[6] H. Soininen,et al. Functional screening of Alzheimer risk loci identifies PTK2B as an in vivo modulator and early marker of Tau pathology , 2016, Molecular Psychiatry.
[7] A. Rodal,et al. Membrane Charge Directs the Outcome of F-BAR Domain Lipid Binding and Autoregulation. , 2015, Cell reports.
[8] J. Lambert,et al. Tau phosphorylation regulates the interaction between BIN1’s SH3 domain and Tau’s proline-rich domain , 2015, Acta neuropathologica communications.
[9] T. Baumgart,et al. BIN1 Membrane Curvature Sensing and Generation Show Autoinhibition Regulated by Downstream Ligands and PI(4,5)P2 , 2014, Biochemistry.
[10] J. Laporte,et al. Amphiphysin 2 (BIN1) in physiology and diseases , 2014, Journal of Molecular Medicine.
[11] T. Baumgart,et al. Intradimer/Intermolecular Interactions Suggest Autoinhibition Mechanism in Endophilin A1 , 2014, Journal of the American Chemical Society.
[12] Christopher A. Waudby,et al. Protein folding on the ribosome studied using NMR spectroscopy , 2013, Progress in nuclear magnetic resonance spectroscopy.
[13] Thomas W. Mühleisen,et al. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease , 2013, Nature Genetics.
[14] M. Owen,et al. Increased expression of BIN1 mediates Alzheimer genetic risk by modulating tau pathology , 2013, Molecular Psychiatry.
[15] P. Permi,et al. SH3 domain ligand binding: What's the consensus and where's the specificity? , 2012, FEBS letters.
[16] Xinchen Wang,et al. Tissue-specific alternative splicing remodels protein-protein interaction networks. , 2012, Molecular cell.
[17] T. Sixma,et al. Enabling high-throughput ligation-independent cloning and protein expression for the family of ubiquitin specific proteases. , 2011, Journal of structural biology.
[18] A. Ittner,et al. Brief update on different roles of tau in neurodegeneration , 2011, IUBMB life.
[19] P. Bosco,et al. APOE and Alzheimer disease: a major gene with semi-dominant inheritance , 2011, Molecular Psychiatry.
[20] Jürgen Götz,et al. Amyloid-β and tau — a toxic pas de deux in Alzheimer's disease , 2011, Nature Reviews Neuroscience.
[21] Ezzie Hutchinson,et al. Systems neuroscience: The stress of dieting , 2011, Nature Reviews Neuroscience.
[22] Sudha Seshadri,et al. Genome-wide analysis of genetic loci associated with Alzheimer disease. , 2010, JAMA.
[23] L. Kiemeney,et al. Corrigendum: Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer , 2009, Nature Genetics.
[24] P. Bosco,et al. Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease , 2009, Nature Genetics.
[25] Thomas Szyperski,et al. A structure-based model of the c-Myc/Bin1 protein interaction shows alternative splicing of Bin1 and c-Myc phosphorylation are key binding determinants. , 2005, Journal of molecular biology.
[26] Wayne Boucher,et al. The CCPN data model for NMR spectroscopy: Development of a software pipeline , 2005, Proteins.
[27] C. Dobson,et al. Heteronuclear NMR investigations of dynamic regions of intact Escherichia coli ribosomes. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[28] M. Akke,et al. Conformation and dynamics of ribosomal stalk protein L12 in solution and on the ribosome. , 2004, Biochemistry.
[29] B. Peter,et al. BAR Domains as Sensors of Membrane Curvature: The Amphiphysin BAR Structure , 2004, Science.
[30] Markus R Wenk,et al. Amphiphysin 2 (Bin1) and T-Tubule Biogenesis in Muscle , 2002, Science.
[31] A. Delacourte,et al. Tau pathology: a marker of neurodegenerative disorders , 2000, Current opinion in neurology.
[32] Pietro De Camilli,et al. Functional partnership between amphiphysin and dynamin in clathrin-mediated endocytosis , 1999, Nature Cell Biology.
[33] Robert Wechsler-Reya,et al. BIN1 is a novel MYC–interacting protein with features of a tumour suppressor , 1996, Nature Genetics.
[34] P. De Camilli,et al. A role of amphiphysin in synaptic vesicle endocytosis suggested by its binding to dynamin in nerve terminals. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[35] S. Schreiber,et al. Two binding orientations for peptides to the Src SH3 domain: development of a general model for SH3-ligand interactions. , 1995, Science.
[36] Hongtao Yu,et al. Structural basis for the binding of proline-rich peptides to SH3 domains , 1994, Cell.
[37] P Cicchetti,et al. Identification of a ten-amino acid proline-rich SH3 binding site. , 1993, Science.
[38] M. Murphy,et al. Bridging integrator 1 (BIN1) protein expression increases in the Alzheimer's disease brain and correlates with neurofibrillary tangle pathology. , 2014, Journal of Alzheimer's disease : JAD.
[39] Nick C Fox,et al. Letter abstract - Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's Disease , 2009 .
[40] Wendell A. Lim,et al. Structural determinants of peptide-binding orientation and of sequence specificity in SH3 domains , 1995, Nature.